home All News open_in_new Full Article

AdvanCell Proudly Announces $18M in Federal Funding from the Medical Research Future Fund (MRFF) Frontiers Initiative for ‘Defeating Prostate Cancer with Targeted Alpha Therapy’

SYDNEY — AdvanCell, a clinical-stage radiopharmaceutical company developing innovative cancer therapeutics, today announced $18M in Australian Federal Government Funding from the Medical Research Future Fund (MRFF) Frontiers Initiative for ‘Defeating Prostate Cancer with Targeted Alpha Therapy’. One out of eight men develops prostate cancer. With the support from the Medical Research Future Fund (MRFF) Frontiers […]


today 3 w. ago attach_file Economics

attach_file Other
attach_file Economics
attach_file Other
attach_file Other
attach_file Economics
attach_file Politics
attach_file Transport
attach_file Politics
attach_file Politics
attach_file Economics
attach_file Economics


ID: 3158763226
Add Watch Country

arrow_drop_down